This entry covers evaluation under DC 6524. A clinician establishes the diagnosis separately.
How is it connected to service?
The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.
Explore service-connection evidence →What do the rating levels describe?
A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.
Compare these levels with the original rating table
Find DC 6524 in the rating schedule
The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.
| Rating | |
|---|---|
| Rhinoscleroma | 50 |
| With permanent hypertrophy of turbinates and with greater than 50-percent obstruction of nasal passage on both sides or complete obstruction on one side | 10 |
| 6524 Granulomatous rhinitis: | |
| Wegener's granulomatosis, lethal midline granuloma | 100 |
| Other types of granulomatous infection | 20 |
| DISEASES OF THE TRACHEA AND BRONCHI | |
| 6600 Bronchitis, chronic: | |
| FEV-1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV-1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy | 100 |
| FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to 55 percent, or; DLCO (SB) of 40- to 55-percent predicted, or; maximum oxygen consumption of 15 to 20 ml/kg/min (with cardiorespiratory limit) | 60 |
Which evidence addresses the questions?
- Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
- Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
- Symptoms and episodes: Records or statements documenting symptoms, severity, frequency, duration, and episodes.
- Clinical findings: Examination findings that are relevant to the public DBQ or rating criteria.
- Scars and residual findings: Records describing relevant scars and residual physical findings.
- Functional impact: Medical and lay evidence describing work and daily-activity effects.
- Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
Find evidence in the Sinusitis, Rhinitis and Other Conditions of the Nose, Throat, Larynx and Pharynx questionnaire
Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.
- diagnosis · p. 1, 2
- medical history · p. 2
- nose, throat, larynx or pharynx conditions · p. 3
- sinusitis · p. 3, 4
- rhinitis · p. 4
- larynx and pharynx conditions · p. 4, 5, 6
- deviated nasal septum · p. 6
- tumors and neoplasms · p. 6, 7
- other pertinent physical findings, complications, conditions, signs, symptoms, and scars · p. 7, 8
- diagnostic testing · p. 8, 9
- functional impact · p. 9
- remarks · p. 9
Shared library and examination references
How an independent medical review works →Sources and scope
Clinical and evidence sources
Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.